No profile data available.
Tevogen Bio Holdings Inc. (TVGN) is a healthcare company in the antiviral pharmaceuticals industry, based in Warren, United States, with about 18 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$26.28 million. Its market capitalization was $44.15 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.
Tevogen Bio reported $0 in revenue for fiscal year 2025.
$44.15 million as of October 9, 2026.
Listed companies of a similar size in the same industry (antiviral pharmaceuticals) include Verrica Pharmaceuticals Inc. (VRCA), Kalaris Therapeutics, Inc. (KLRS), Serina Therapeutics, Inc. (SER), NanoViricides, Inc. (NNVC).